Activation, regulation, and inhibition of DYRK1A - PubMed (original) (raw)
Review
. 2011 Jan;278(2):246-56.
doi: 10.1111/j.1742-4658.2010.07956.x. Epub 2010 Dec 3.
Affiliations
- PMID: 21126318
- DOI: 10.1111/j.1742-4658.2010.07956.x
Free article
Review
Activation, regulation, and inhibition of DYRK1A
Walter Becker et al. FEBS J. 2011 Jan.
Free article
Abstract
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiology. Higher than normal levels of DYRK1A are associated with the pathology of neurodegenerative diseases and have been implicated in some neurobiological alterations of Down syndrome, such as mental retardation. It is therefore important to understand the molecular mechanisms that control the activity of DYRK1A. Here we review the current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases. However, tyrosine phosphorylation does not appear to regulate the enzymatic activity of DYRK1A. Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins and regulated nuclear translocation. Finally, we compare the properties of small molecule inhibitors that target DYRK1A and evaluate their potential application and limitations. The β-carboline alkaloid harmine is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.
© 2010 The Authors Journal compilation © 2010 FEBS.
Similar articles
- Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
Göckler N, Jofre G, Papadopoulos C, Soppa U, Tejedor FJ, Becker W. Göckler N, et al. FEBS J. 2009 Nov;276(21):6324-37. doi: 10.1111/j.1742-4658.2009.07346.x. Epub 2009 Oct 1. FEBS J. 2009. PMID: 19796173 - Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.
Adayev T, Chen-Hwang MC, Murakami N, Lee E, Bolton DC, Hwang YW. Adayev T, et al. Biochemistry. 2007 Jun 26;46(25):7614-24. doi: 10.1021/bi700251n. Epub 2007 May 31. Biochemistry. 2007. PMID: 17536841 - Regulation of Dyrk1A kinase activity by 14-3-3.
Kim D, Won J, Shin DW, Kang J, Kim YJ, Choi SY, Hwang MK, Jeong BW, Kim GS, Joe CO, Chung SH, Song WJ. Kim D, et al. Biochem Biophys Res Commun. 2004 Oct 15;323(2):499-504. doi: 10.1016/j.bbrc.2004.08.102. Biochem Biophys Res Commun. 2004. PMID: 15369779 - MNB/DYRK1A as a multiple regulator of neuronal development.
Tejedor FJ, Hämmerle B. Tejedor FJ, et al. FEBS J. 2011 Jan;278(2):223-35. doi: 10.1111/j.1742-4658.2010.07954.x. Epub 2010 Dec 13. FEBS J. 2011. PMID: 21156027 Review. - Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Jarhad DB, Mashelkar KK, Kim HR, Noh M, Jeong LS. Jarhad DB, et al. J Med Chem. 2018 Nov 21;61(22):9791-9810. doi: 10.1021/acs.jmedchem.8b00185. Epub 2018 Jul 20. J Med Chem. 2018. PMID: 29985601 Review.
Cited by
- Regulatory mechanisms governing GLI proteins in hedgehog signaling.
Yoshida S, Yoshida K. Yoshida S, et al. Anat Sci Int. 2024 Nov 22. doi: 10.1007/s12565-024-00814-1. Online ahead of print. Anat Sci Int. 2024. PMID: 39576500 Review. - Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration.
Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ. Sobral AF, et al. Int J Mol Sci. 2024 Aug 28;25(17):9339. doi: 10.3390/ijms25179339. Int J Mol Sci. 2024. PMID: 39273288 Free PMC article. Review. - Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation.
Góral I, Wichur T, Sługocka E, Grygier P, Głuch-Lutwin M, Mordyl B, Honkisz-Orzechowska E, Szałaj N, Godyń J, Panek D, Zaręba P, Sarka A, Żmudzki P, Latacz G, Pustelny K, Bucki A, Czarna A, Menezes F, Więckowska A. Góral I, et al. ACS Chem Neurosci. 2024 Sep 4;15(17):3181-3201. doi: 10.1021/acschemneuro.4c00365. Epub 2024 Aug 19. ACS Chem Neurosci. 2024. PMID: 39158934 Free PMC article. - Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer's Disease-Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors.
Góral I, Wichur T, Sługocka E, Godyń J, Szałaj N, Zaręba P, Głuch-Lutwin M, Mordyl B, Panek D, Więckowska A. Góral I, et al. Molecules. 2024 Jun 2;29(11):2616. doi: 10.3390/molecules29112616. Molecules. 2024. PMID: 38893493 Free PMC article. - Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A.
Miyata Y, Nishida E. Miyata Y, et al. Life Sci Alliance. 2023 Oct 6;6(12):e202302129. doi: 10.26508/lsa.202302129. Print 2023 Dec. Life Sci Alliance. 2023. PMID: 37802655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources